Advertisement

Research Article Free access | 10.1172/JCI2338

LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.

N Lamping, R Dettmer, N W Schröder, D Pfeil, W Hallatschek, R Burger, and R R Schumann

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, D-10098, Berlin, Germany.

Find articles by Lamping, N. in: PubMed | Google Scholar

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, D-10098, Berlin, Germany.

Find articles by Dettmer, R. in: PubMed | Google Scholar

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, D-10098, Berlin, Germany.

Find articles by Schröder, N. in: PubMed | Google Scholar

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, D-10098, Berlin, Germany.

Find articles by Pfeil, D. in: PubMed | Google Scholar

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, D-10098, Berlin, Germany.

Find articles by Hallatschek, W. in: PubMed | Google Scholar

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, D-10098, Berlin, Germany.

Find articles by Burger, R. in: PubMed | Google Scholar

Institut für Mikrobiologie und Hygiene, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, D-10098, Berlin, Germany.

Find articles by Schumann, R. in: PubMed | Google Scholar

Published May 15, 1998 - More info

Published in Volume 101, Issue 10 on May 15, 1998
J Clin Invest. 1998;101(10):2065–2071. https://doi.org/10.1172/JCI2338.
© 1998 The American Society for Clinical Investigation
Published May 15, 1998 - Version history
View PDF
Abstract

LPS-binding protein (LBP) recognizes bacterial LPS and transfers it to CD14, thereby enhancing host cell stimulation, eventually resulting in pathogenic states such as septic shock. Recently, LBP also was shown to detoxify LPS by transferring LPS into HDL particles in vitro. Thus, the predominant in vivo function of LBP has remained unclear. To investigate the biological activity of acute phase concentrations of recombinant murine LBP, high concentrations of LBP were investigated in vitro and in vivo. Although addition of low concentrations of LBP to a murine macrophage cell line enhanced LPS-induced TNF-alpha synthesis, acute phase concentrations of LBP blocked this effect in comparison to low-dose LBP. When injected into mice intraperitoneally, LBP inhibited LPS-mediated cytokine release and prevented hepatic failure resulting in a significantly decreased mortality rate in LPS-challenged and D-galactosamine-sensitized mice, as well as in a murine model of bacteremia. These results complement a recent study revealing LBP-deficient mice to be dramatically more susceptible to an intraperitoneal Salmonella infection as compared with normal mice. We conclude that acute phase LBP has a protective effect against LPS and bacterial infection and may represent a physiologic defense mechanism against infection. Despite the limitations of any murine sepsis model, the results shown may imply that LBP could have beneficial effects during gram-negative peritonitis in humans.

Version history
  • Version 1 (May 15, 1998): No description
Advertisement
Advertisement